CDST: A Potential Drug Target and Biomarker for Diseases (G112268240)
CDST: A Potential Drug Target and Biomarker for Diseases
CCDST (long non-coding RNA) is a molecule that has been identified as a potential drug target and biomarker for a variety of diseases, including cancer. CCDST is a non-coding RNA molecule that is derived from the cytoskeleton and is involved in the regulation of cell division and growth. It is expressed in a variety of tissues and cells and has been shown to play a role in the development and progression of a number of diseases, including cancer.
One of the key features of CCDST is its ability to interact with a variety of different molecules, including proteins that are involved in the regulation of cell division and growth. This interaction between CCDST and these molecules is thought to be responsible for its potential as a drug target.
In addition to its potential as a drug target, CCDST has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that changes in the levels of CCDST can be associated with the development of certain diseases, such as cancer. Additionally, CCDST has been shown to be expressed in a variety of biological samples, including blood, saliva, and urine, which could make it a useful biomarker for a variety of diseases.
Another potential mechanism by which CCDST may be involved in the development and progression of certain diseases is its role in the regulation of cellular signaling pathways. For example, studies have shown that CCDST can interact with proteins that are involved in the regulation of cell growth and differentiation, and that changes in these signaling pathways can be associated with the development of certain diseases.
In conclusion, CCDST is a molecule that has the potential to be a drug target and biomarker for a variety of diseases. Its ability to interact with a variety of different molecules and its role in the regulation of cellular signaling pathways make it an attractive target for further research. Further studies are needed to fully understand the potential of CCDST as a drug and biomarker and to determine its utility in the treatment of various diseases.
Protein Name: Cervical Cancer Associated DHX9 Suppressive Transcript
The "CCDST Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDST comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9
